Suchergebnisse - "Curigliano, G"

PubPharm (286)

81

Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Lenihan, D. | Fradley, M. | +27

82

Corrigendum to "EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants" [Breast 44 (April 2019) 90-93

enthalten in: Breast (Edinburgh, Scotland) | 2019

von Cardoso, M. | Wyld, L. | Rubio, I. | +5

ErratumFor: Breast. 2019 Apr;44:90-93. - PMID 30703669

83

Corrigendum to "About the French prohibition of textured breast implants : Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position" [Breast 46 (August 2019) 95-96

enthalten in: Breast (Edinburgh, Scotland) | 2019

von Cardoso, M. | Biganzoli, L. | Rubio, I. | +6

ErratumFor: Breast. 2019 Aug;46:95-96. - PMID 31125932

84

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Park, J. | Jonas, S. | Bataillon, G. | +11

CommentIn: Ann Oncol. 2019 Dec 1;30(12):1849-1850. - PMID 31626275

85

Estimating the benefits of therapy for early-stage breast cancer : the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Burstein, H. | Curigliano, G. | Loibl, S. | +11

CommentIn: Ann Oncol. 2019 Oct 1;30(10):1533-1535. - PMID 31504122

86

De-escalating and escalating treatments for early-stage breast cancer : the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Curigliano, G. | Burstein, H. | P Winer, E. | +52

ErratumFor: Ann Oncol. 2017 Aug 1;28(8):1700-1712. - PMID 28838210

87

T-cell bispecific antibodies to bypass MHC class I loss in breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Marra, A. | Curigliano, G.

CommentOn: Ann Oncol. 2019 Jun 1;30(6):934-944. - PMID 30924846

88

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants

enthalten in: Breast (Edinburgh, Scotland) | 2019

von Cardoso, M. | Wyld, L. | Rubio, I. | +5

ErratumIn: Breast. 2019 Dec;48:102. - PMID 31706463

89

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer : cohort A of the phase II KEYNOTE-086 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Adams, S. | Schmid, P. | Rugo, H. | +18

CommentIn: Ann Oncol. 2019 Mar 1;30(3):347-348. - PMID 30753266

90

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Luen, S. | Salgado, R. | Dieci, M. | +14